That said, clinical trials have shown that participants typically lose about six percent of their body weight over the course of three months on the medication
In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids. Incretin hormones are released whenever food is consumed
If the next day has arrived, skip the missed dose entirely
Even for someone fully titrated to 2.4 mg weekly, this represents a significant overdose
How Klinic Works Heres how you can start your weight loss journey in The Villages with Klinic: Step 1: Insurance Verification Complete a simple intake form including your health history and insurance information
This dual-action medication targets both GLP-1 and GIP (glucose-dependent insulin tropic polypeptide) receptors, amplifying its effectiveness in weight reduction
